ask="25.53"
ask_size="100"
average_daily_volume="376773"
bid="N/A"
bid_size="N/A"
book_value="8.16"
change="+0.77"
change_from_200_day_moving_average="1.03"
change_from_50_day_moving_average="1.19"
change_from_52_week_high="-3.44"
change_From_52_week_low="9.53"
change_in_percent="+3.78%"
close="21.13"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.14"
ebitda="-16.56M"
eps_estimate_current_year="-1.32"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.11"
ex_dividend_date="N/A"
float_shares="21374000"
high="21.32"
high_52_weeks="24.57"
last_trade_date="2/27/2017"
last_trade_price="21.13"
last_trade_size="38459"
last_trade_time="4:00pm"
low="20.26"
low_52_weeks="11.60"
market_capitalization="797.28M"
moving_average_200_day="20.10"
moving_average_50_day="19.94"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="34.67"
open="20.26"
pe_ratio="N/A"
peg_ratio="-0.79"
percent_change_from_200_day_moving_average="+5.12%"
percent_change_from_50_day_moving_average="+5.99%"
percent_change_from_52_week_high="-14.00%"
percent_change_from_52_week_low="+82.16%"
previous_close="20.36"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.50"
price_per_sales="6.06"
revenue="126.71M"
shares_outstanding="37732000"
short_ratio="13.94"
stock_exchange="NGM"
symbol="RTRX"
volume="619765"
weeks_range_52="11.60 - 24.57"
